// App-Quantinova.ai

: THE USE OF THE TRANSCRIPTOMIC SIGNATURE OF MESENCHYMAL STROMAL CELLS FROM VARIOUS SOURCES TO HELP DECIDE THE OPTIMAL SOURCE FOR CARTILAGE REGENERATION

Researchers

Presenter

  • Isobel Darlington

Principal Investigators

  • Antonia Vogt

  • Eleanor C Williams

  • Roger Brooks

  • Mark Birch

  • Irina Mohorianu

  • Wasim Khan

  • Andrew McCaskie

Medical Centers

  • Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom

  • University of Cambridge, Department of Surgery, Division of Trauma and Orthopaedic Surgery, Cambridge, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • Cluster of Differentiation 105 Antigen

  • Cluster of Differentiation 44

  • Mesenchymal stem cells

  • Thy-1 Cell Surface Antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved